These major metabolic alterations induced by upregulated Wnt/beta-catenin signaling and downregulated PPAR gamma may partly account for the frequently encountered association between type 2 diabetes and colon cancer. The gene discussed is CTNNB1; the disease is malignant colon neoplasm.